Daxas迪開舒

Daxas Dosage/Direction for Use

Manufacturer:

AstraZeneca

Distributor:

Zuellig
Full Prescribing Info
Dosage/Direction for Use
Posology: The recommended dose is 500 micrograms (one tablet) roflumilast once daily.
Daxas may need to be taken for several weeks to achieve its effect (see Pharmacology: Pharmacodynamics under Actions). Daxas has been studied in clinical trials for up to one year.
Special populations: Elderly: No dose adjustment is necessary.
Renal impairment: No dose adjustment is necessary.
Hepatic impairment: The clinical data with Daxas in patients with mild hepatic impairment classified as Child-Pugh A are insufficient to recommend a dose adjustment (see Pharmacology: Pharmacokinetics under Actions) and therefore Daxas should be used with caution in these patients.
Patients with moderate or severe hepatic impairment classified as Child-Pugh B or C must not take Daxas (see Contraindications).
Paediatric population: There is no relevant use of Daxas in the paediatric population (under 18 years) in the indication COPD.
Method of administration: For oral use.
The tablet should be swallowed with water and taken at the same time every day. The tablet can be taken with or without food.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in